Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Evaluate Safety and Efficacy of PBK_M2502
Sponsor: Pharmbio Korea Co., Ltd.
Summary
This clinical trial was prospective, randomized, single-blind, 3-treatment arm, parallel treatment group, and active-controlled. , Multi-center, Phase 3 confirmatory clinical trial.
Official title: A Prospective, Randomized, Parallel, Multi-center, Phase 3 Trial to Evaluate Safety and Efficacy of PBK_M2502
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
INTERVENTIONAL
Enrollment
110
Start Date
2025-08
Completion Date
2026-11
Last Updated
2025-08-11
Healthy Volunteers
Yes
Interventions
PBK_M2502 1-Day
Subjects who are randomized into group test 2 will receive bowel preparation on the same-day.
PBK_M2502 2-Day
Subjects who are randomized into group test 1 will receive bowel preparation from evening to next morning.
Locations (1)
Kyung Hee University Hospital at Gangdong
Seoul, Gangdong-gu, South Korea